Vijeta Sharma
Overview
Explore the profile of Vijeta Sharma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma P, Jiang Q, Li S, Ocke E, Tsotetsi K, Sukheja P, et al.
J Med Chem
. 2025 Mar;
68(5):5774-5803.
PMID: 40035499
A dire need exists for novel drugs to treat infection. In an effort to build on our early efforts targeting the MenG enzyme within the menaquinone biosynthetic pathway, we have...
2.
Meyer C, Garzia A, Miller M, Huggins D, Myers R, Hoffmann H, et al.
Nature
. 2024 Dec;
637(8048):1178-1185.
PMID: 39663451
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rapid development of highly effective vaccines against SARS-CoV-2 has altered the trajectory of the pandemic,...
3.
Alvarez N, Adam G, Howe J, Sharma V, Zimmerman M, Dolgov E, et al.
Viruses
. 2024 Jul;
16(7).
PMID: 39066320
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) continues to be a global threat due to its ability to evolve and generate new subvariants, leading to new waves of infection....
4.
Shurtleff V, Layton M, Parish C, Perkins J, Schreier J, Wang Y, et al.
J Med Chem
. 2024 Feb;
67(5):3935-3958.
PMID: 38365209
As SARS-CoV-2 continues to circulate, antiviral treatments are needed to complement vaccines. The virus's main protease, 3CLPro, is an attractive drug target in part because it recognizes a unique cleavage...
5.
Mane V, Mehta R, Alvarez N, Sharma V, Park S, Fox A, et al.
Hum Vaccin Immunother
. 2024 Jan;
20(1):2303226.
PMID: 38251677
Immunoglobulin A (IgA) is the most abundant antibody (Ab) in human mucosae, with secretory form (sIgA) being dominant and uniquely stable. sIgA is challenging to produce recombinantly but is naturally...
6.
Mane V, Mehta R, Alvarez N, Sharma V, Park S, Fox A, et al.
bioRxiv
. 2023 Sep;
PMID: 37693438
Immunoglobulin A (IgA) is the most abundant antibody (Ab) in human mucosal compartments including the respiratory tract, with the secretory form of IgA (sIgA) being dominant and uniquely stable in...
7.
Kostenko S, Khatua B, Trivedi S, Narayana Pillai A, McFayden B, Morsy M, et al.
Gastroenterology
. 2023 Jun;
165(4):999-1015.
PMID: 37263302
Background & Aims: Although transient bacteremia is common during dental and endoscopic procedures, infections developing during sterile diseases like acute pancreatitis (AP) can have grave consequences. We examined how impaired...
8.
Cartin-Ceba R, Khatua B, El-Kurdi B, Trivedi S, Kostenko S, Imam Z, et al.
iScience
. 2022 May;
25(5):104322.
PMID: 35502320
We compared three hospitalized patient cohorts and conducted mechanistic studies to determine if lipotoxicity worsens COVID-19. Cohort-1 (n = 30) compared COVID-19 patients dismissed home to those requiring intensive-care unit...
9.
Sharma V, Gupta M, Kumar A, Mishra D
Sensors (Basel)
. 2021 Sep;
21(17).
PMID: 34502592
Human action recognition in videos has become a popular research area in artificial intelligence (AI) technology. In the past few years, this research has accelerated in areas such as sports,...
10.
Dangi P, Jain R, Mamidala R, Sharma V, Agarwal S, Bathula C, et al.
Sci Rep
. 2019 Nov;
9(1):17785.
PMID: 31780808
Natural products offer an abundant source of diverse novel scaffolds that inspires development of next generation anti-malarials. With this vision, a library of scaffolds inspired by natural biologically active alkaloids...